Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows.

As the weather begins to get warm, every year, without fail, there is an uptick in canine parvovirus. Canine parvovirus first came into the picture in 1978, when Feline Panleukopenia (a separate virus ...

Altesa BioSciences today announced positive topline results from its Phase 2 placebo-controlled study examining the effects of vapendavir in COPD patients challenged with rhinovirus.  In this study, ...

Influenza viruses are among the most likely triggers of future pandemics. A research team has developed a method that can be used to study the interaction of viruses with host cells in unprecedented ...

The US Food and Drug Administration has approved a type of CRISPR gene-edited pig for human consumption.

As China and the United States trade charges of a lab leak, researchers contend in a new paper that the Covid pandemic got ...

Studies show how spike protein changes determine the risk of viral outbreaks, offering important insights for the future ...

Researchers from the University of São Paulo in Brazil have discovered that silver nanoparticles produced by a fungus called ...

Artificial intelligence algorithms have now been combined with traditional laboratory methods to uncover promising drug leads against human enterovirus 71 (EV71), the pathogen behind most cases of ...

Hariom Yadav, Ph.D., can't get a particular cocktail off his mind—especially because our aging population potentially could ...

Computational analysis shows that silver nanoparticles bind to the spike protein used by the SARS-CoV-2 virus to enter host cells ...